AIT Enters into $32.5 million Commercial Licensing Agreement with Circassia Pharmaceuticals for Its Novel Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and China

Stock Information for AIT Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.